Replay: Expanding Drug Portfolio in Hearing, with Fast-Track Development Strategies

Do you want to know more about how to leverage pharma discovery engine to accelerate innovation in hearing health? How to develop repurposing and co-developing strategies to rapidly advance promising assets to the market?

Find out in the presentation below given by Celia Belline, CILcare’s CEO, at the Inner Ear Disorders Therapeutics Summit 2021, a CILcare-sponsored event on the translation and clinical development of therapeutics that aim to treat inner disorders.

The Inner Ear Disorders Therapeutics Summit is a world-class event that gathers industry and academics experts from the hearing field, as well as innovative biopharmaceutical companies, to discuss the translation and clinical development of therapeutics that aim to treat inner disorders. The 2021 edition took place online on May 25-27 2021, with KOLs adressing key topics, such as the different preclinical modelling approaches for translative proof of concept data and the major challenges to overcome to better treat patients that suffer from inner ear disorders.

Learn more about the event by clicking here.

Share the Post: